Study guide

5.3 Radiopharmaceutical Quality Control

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

5.3 Radiopharmaceutical Quality Control

Key Takeaways Explain This Topic AI

Every preparation needs visual inspection for color, clarity, and particulates before release—except agents that are intentionally particulate (e.g., MAA, sulfur colloid) which have their own appearance criteria

Radiochemical purity (RCP) distinguishes the desired labeled species from free pertechnetate and hydrolyzed-reduced technetium using ITLC or equivalent methods

Typical Tc-99m kit RCP limits are often ≥90% or ≥95% desired species—always use the product-specific package insert limit

Documentation must capture lot numbers, activities, times, QC results, and technologist identity for regulatory and patient-safety traceability

Reject and do not administer preparations that fail visual checks, RCP limits, breakthrough limits, wrong labeling, or expired dating

Last updated: August 2026

Kit preparation is incomplete until quality control clears the product for injection. Domain III pairs visual inspection , radiochemical purity (RCP) , documentation , and clear reject criteria to prevent wrong biodistribution, excess dose, and medication errors.

Visual Inspection

View briefly through shielding under adequate light before relying on chromatography.

  • Observation Expectation If abnormal
  • Color Most Tc-99m agents clear/colorless (some allow pale tint) Reject unexpected color
  • Clarity True solutions clear , no haze Reject unintended cloudiness
  • Particulates None in solutions Reject fibers, precipitates, foreign matter

Intentional particles MAA , sulfur colloid : uniform suspension, no large clumps Reject clumped/aggregated product

Integrity Intact vial/septum, plausible volume Reject damaged containers

Visual failure alone is enough to stop —good ITLC does not salvage a dirty vial. Looking normal also does not prove RCP; visual checks are necessary but not sufficient .

Radiochemical Purity and ITLC

Radiochemical purity is the fraction of total radioactivity in the desired chemical form . For Tc-99m kits, classic impurities are:

Free pertechnetate (TcO₄⁻) — unbound oxidized Tc; often localizes in stomach, thyroid, salivary glands .

Hydrolyzed-reduced Tc (HR-Tc) — colloidal reduced impurity; often liver, spleen, marrow .

ITLC (or paper chromatography) uses kit-specific strips and solvents to separate species. Conceptual two-system model:

  • Generic system Often migrates Often at origin
  • System A (e.g., saline/acetone-type, kit-dependent) Free TcO₄⁻ in many methods Bound complex + HR-Tc
  • System B (kit-specific) Bound complex (± free tech) HR-Tc

Count strip sections (well counter, dose calibrator, or scanner per SOP): % desired = 100 % − % free TcO 4 − − % HR-Tc \%\ \text{desired} = 100\% - \%\text{free TcO}_4^- - \%\text{HR-Tc} % desired = 100% − % free TcO 4 − ​ − % HR-Tc

Exact solvents and cut lines are product-method specific . The exam cares that you know what free tech and HR-Tc are and that RCP = desired fraction .

Worked example 1 — RCP

Impurities: 4% free TcO₄⁻ + 3% HR-Tc → desired 93% . Passes a ≥90% limit; fails ≥95% .

Worked example 2 — Image clue

Unexpected stomach/thyroid on a bone scan suggests free pertechnetate —why RCP is done before imaging, not after a ruined study.

Typical Purity Limits and Purity Types

  • Product / test Common teaching limit
  • Many Tc-99m kits ≥90% desired species
  • Stricter Tc-99m kits ≥95% (use the insert)
  • Mo-99 in eluate ≤0.15 μCi Mo / mCi Tc at admin
  • Al³⁺ ≤10 μg/mL
  • I-131, In-111, others Product-specific
  • Purity type Question Example
  • Radiochemical Correct chemical form? ITLC free TcO₄⁻ / HR-Tc
  • Radionuclidic Correct radionuclide? Mo-99 breakthrough
  • Chemical Nonradioactive impurities OK? Al³⁺ test
  • Microbial Sterile process maintained? Asepsis / sterility programs

Do not confuse radiochemical (wrong form of Tc) with radionuclidic (wrong nuclide such as Mo-99).

Documentation and Labeling

Trace every dose from patient → kit lot → generator elution when applicable. Record:

  • Product name/route , kit lot , generator/eluate ID if used
  • Preparation activity, volume, concentration, time, expiration
  • QC results : visual, RCP %, Mo-99 ratio, Al³⁺ as required
  • Technologist ID / instrument ID per policy
  • Patient syringe: prescribed vs assayed activity, assay time, volume

Syringe labels must stay legible: drug, activity, time, patient identifiers. A mislabeled syringe is a critical event even if chemistry was perfect. Keep paper or electronic records long enough to satisfy license, state, and institutional retention rules.

When to Reject

Do not administer if any apply:

Failed visual inspection (wrong color, unexpected particles, clumped MAA).

RCP below insert limit.

Mo-99 > 0.15 μCi/mCi Tc at admin time .

Al³⁺ > 10 μg/mL (or other chemical limits).

Expired kit or post-reconstitution dating exceeded.

Wrong product/lot or unresolvable labeling error.

Activity/volume outside allowed range when SOP requires discard.

Compromised sterility or temperature abuse per policy.

Worked example 3 — Reject

MDP looks clear; ITLC 6% free + 5% HR-Tc = 89% desired; limit ≥90% . Reject , remake, investigate (old eluate, excess activity, air), document—do not inject hoping the scan will be fine.

Worked example 4 — Release

Sestamibi: visual OK; RCP 96% (limit ≥90%); within activity/volume limits; within dating; labels complete → release .

Chain of Custody for Quality

Generator QC (assay, Mo-99, Al³⁺) → kit within limits → visual + RCP → assayed labeled dose → inject before expiration. Break any link → stop.

Match failure to test: thyroid/stomach → free TcO₄⁻; liver/spleen on non-colloid study → HR-Tc; held eluate with rising Mo ratio → breakthrough; pediatric lung issues → particle number , not mCi alone.

If QC fails, quarantine the vial, label it not for use, notify the supervising pharmacist/authorized user or RSO per SOP, and prepare a replacement only after the cause is addressed when time allows. Never “top off” a failed kit with more pertechnetate hoping purity will improve without a validated procedure.

Exam hooks: visual first; ITLC for free TcO₄⁻ and HR-Tc ; limits often ≥90–95% ; full documentation; written limit failed → reject .